2m 2m 2m 2m 2m 2m 2m
ENGENE THERAP (ENGN)
NASDAQ
$1.58-$0.05 (-2.88%)
Price as of Oct 22, 2026 7:57 PM EDT- $109.2MMarket Cap
- -79.88%1-Year Change
- BiotechnologyIndustry
ENGENE THERAP (ENGN)
$1.58-$0.05 (-2.88%)
ENGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.63 | ||
Change | -$0.04 (-2.40%) | ||
Open | $1.68 | ||
High | $1.68 | ||
Low | $1.59 | ||
Previous Close | $1.67 | ||
Volume | 1,108,892 | ||
30-Day Average Volume | 871,871 | ||
1-Week Change | 4.49% | ||
1-Month Change | -16.84% | ||
1-Year Change | -79.88% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.0M | ||
Total Assets | $288.3M | ||
Market Cap | $109.2M | ||
Enterprise Value | $93.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.5M | ||
Free Cash Flow | -$18.9M | ||
EBIT | -$31.7M | ||
EBITDA | -$31.5M | ||
Net Working Capital | $250.7M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 08/03/2015 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue